Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice

  • Authors: Belardo C.1, Jebali J.2, Boccella S.3, Infantino R.4, Fusco A.3, Perrone M.5, Bonsale R.4, Manzo I.4, Iannotta M.4, Scuteri D.6, Ferraraccio F.7, Panarese I.7, Ferrara G.7, Guida F.4, Luongo L.4, Palazzo E.4, Srairi-Abid N.8, Marrakchi N.9, Maione S.4
  • Affiliations:
    1. Department of Experimental Medicine, harmacology Division, University of Campania "L. Vanvitelli"
    2. Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis, University of Tunis El Manar
    3. Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli
    4. Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"
    5. Department of Experimental Medicine, Pharmacology Division, University of Campania "L
    6. Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria
    7. Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania"L. Vanvitelli"
    8. Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis,, University of Tunis El Manar,
    9. Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis,, University of Tunis El Manar
  • Issue: Vol 22, No 8 (2024)
  • Pages: 1391-1405
  • Section: Neurology
  • URL: https://hum-ecol.ru/1570-159X/article/view/644874
  • DOI: https://doi.org/10.2174/1570159X22999231207105743
  • ID: 644874

Cite item

Full Text

Abstract

Background:Integrins, important extracellular matrix (ECM) receptor proteins, are affected by inflammation and can participate in the maintenance of many painful conditions. Although they are ubiquitous and changeable across all cell types, the roles of these cell adhesion molecules in pathological pain have not been fully explored.

Objective:We evaluated the effects of the subcutaneous injection of lebecetin, a C-type lectin isolated from Macrovipera lebetina snake venom, previously reported to inhibit α5β1 and αv integrin activity, on different components of inflammation induced by the formalin administration in the hind paw of mice.

Methods:The formalin-induced nocifensive behavior, edema, and histopathological changes in the hind paw associated with cytokine, iNOS, and COX2 expression, nociceptive-specific neuron activity, and microglial activation analysis in the spinal cord were evaluated in mice receiving vehicle or lebecetin pretreatment.

Results:Lebecetin inhibited the nocifensive responses in the formalin test, related edema, and cell infiltration in the injected paw in a biphasic, hormetic-like, and dose-dependent way. According to that hormetic trend, a reduction in pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha and upregulation of the anti-inflammatory cytokine IL-10 in the spinal cord were found with the lowest doses of lebecetin. Moreover, COX2 and iNOS expression in serum and spinal cord followed the same biphasic pattern of cytokines. Finally, nociceptive neurons sensitization and activated microglia were normalized in the dorsal horn of the spinal cord by lebecetin.

Conclusion:These findings implicate specific roles of integrins in inflammation and tonic pain, as well as in the related central nervous system sequelae.

About the authors

Carmela Belardo

Department of Experimental Medicine, harmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Jed Jebali

Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis, University of Tunis El Manar

Email: info@benthamscience.net

Serena Boccella

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli

Email: info@benthamscience.net

Rosmara Infantino

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Antimo Fusco

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli

Email: info@benthamscience.net

Michela Perrone

Department of Experimental Medicine, Pharmacology Division, University of Campania "L

Email: info@benthamscience.net

Roozbe Bonsale

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Iolanda Manzo

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Monica Iannotta

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Damiana Scuteri

Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria

Author for correspondence.
Email: info@benthamscience.net

Franca Ferraraccio

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania"L. Vanvitelli"

Email: info@benthamscience.net

Iacopo Panarese

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania"L. Vanvitelli"

Email: info@benthamscience.net

Giovanna Ferrara

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania"L. Vanvitelli"

Email: info@benthamscience.net

Francesca Guida

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Livio Luongo

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Enza Palazzo

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Email: info@benthamscience.net

Najet Srairi-Abid

Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis,, University of Tunis El Manar,

Email: info@benthamscience.net

Naziha Marrakchi

Laboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis,, University of Tunis El Manar

Email: info@benthamscience.net

Sabatino Maione

Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli"

Author for correspondence.
Email: info@benthamscience.net

References

  1. del Río-Portilla, F.; Hernández-Marín, E.; Pimienta, G.; Coronas, F.V.; Zamudio, F.Z.; Rodríguez de la Vega, R.C.; Wanke, E.; Possani, L.D. NMR solution structure of Cn12, a novel peptide from the Mexican scorpion Centruroides noxius with a typical beta-toxin sequence but with alpha-like physiological activity. Eur. J. Biochem., 2004, 271(12), 2504-2516. doi: 10.1111/j.1432-1033.2004.04181.x PMID: 15182366
  2. Rodríguez de la Vega, R.C.; Possani, L.D. Current views on scorpion toxins specific for K+-channels. Toxicon, 2004, 43(8), 865-875. doi: 10.1016/j.toxicon.2004.03.022 PMID: 15208019
  3. Patil, C.G.; Walker, D.G.; Miller, D.M.; Butte, P.; Morrison, B.; Kittle, D.S.; Hansen, S.J.; Nufer, K.L.; Byrnes-Blake, K.A.; Yamada, M.; Lin, L.L.; Pham, K.; Perry, J.; Parrish-Novak, J.; Ishak, L.; Prow, T.; Black, K.; Mamelak, A.N. Phase 1 safety, pharmacokinetics, and fluorescence imaging study of Tozuleristide (BLZ-100) in adults with newly diagnosed or recurrent gliomas. Neurosurgery, 2019, 85(4), E641-E649. doi: 10.1093/neuros/nyz125 PMID: 31069381
  4. McDermott, A. Venom back in vogue as a wellspring for drug candidates. Proc. Natl. Acad. Sci. USA, 2020, 117(19), 10100-10104. doi: 10.1073/pnas.2004486117 PMID: 32321825
  5. Pucca, M.B.; Peigneur, S.; Cologna, C.T.; Cerni, F.A.; Zoccal, K.F.; Bordon, K.C.F.; Faccioli, L.H.; Tytgat, J.; Arantes, E.C. Electrophysiological characterization of the first Tityus serrulatus alpha-like toxin, Ts5: Evidence of a pro-inflammatory toxin on macrophages. Biochimie, 2015, 115, 8-16. doi: 10.1016/j.biochi.2015.04.010 PMID: 25906692
  6. Jiménez-Vargas, J.M.; Restano-Cassulini, R.; Possani, L.D. Toxin modulators and blockers of hERG K+ channels. Toxicon, 2012, 60(4), 492-501. doi: 10.1016/j.toxicon.2012.03.024 PMID: 22497787
  7. Cerni, F.A.; Pucca, M.B.; Amorim, F.G.; de Castro Figueiredo Bordon, K.; Echterbille, J.; Quinton, L.; De Pauw, E.; Peigneur, S.; Tytgat, J.; Arantes, E.C. Isolation and characterization of Ts19 Fragment II, a new long-chain potassium channel toxin from Tityus serrulatus venom. Peptides, 2016, 80, 9-17. doi: 10.1016/j.peptides.2015.06.004 PMID: 26116782
  8. Siigur, J.; Aaspõllu, A.; Siigur, E. Biochemistry and pharmacology of proteins and peptides purified from the venoms of the snakes Macrovipera lebetina subspecies. Toxicon, 2019, 158, 16-32. doi: 10.1016/j.toxicon.2018.11.294 PMID: 30472110
  9. Bazaa, A.; Luis, J.; Srairi-Abid, N.; Kallech-Ziri, O.; Kessentini-Zouari, R.; Defilles, C.; Lissitzky, J.C.; El Ayeb, M.; Marrakchi, N. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration. Matrix Biol., 2009, 28(4), 188-193. doi: 10.1016/j.matbio.2009.03.007 PMID: 19351557
  10. Zouari-Kessentini, R.; Luis, J.; Karray, A.; Kallech-Ziri, O.; Srairi-Abid, N.; Bazaa, A.; Loret, E.; Bezzine, S.; El Ayeb, M.; Marrakchi, N. Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration. Toxicon, 2009, 53(4), 444-453. doi: 10.1016/j.toxicon.2009.01.003 PMID: 19708222
  11. Baîram, D.; Aissa, I.; Louati, H.; Othman, H.; Abdelkafi-Koubaa, Z.; Krayem, N.; El Ayeb, M.; Srairi-Abid, N.; Marrakchi, N.; Gargouri, Y. Biochemical and monolayer characterization of Tunisian snake venom phospholipases. Int. J. Biol. Macromol., 2016, 89, 640-646. doi: 10.1016/j.ijbiomac.2016.05.020 PMID: 27164498
  12. Morjen, M.; Othman, H.; Abdelkafi-Koubaa, Z.; Messadi, E.; Jebali, J.; El Ayeb, M.; Abid, N.S.; Luis, J.; Marrakchi, N. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis. Int. J. Biol. Macromol., 2018, 117, 790-799. doi: 10.1016/j.ijbiomac.2018.05.230 PMID: 29870815
  13. Gasmi, A.; Srairi, N.; Guermazi, S.; Dkhil, H.; Karoui, H.; El Ayeb, M. Amino acid structure and characterization of a heterodimeric disintegrin from Vipera lebetina venom. Biochim. Biophys. Acta Protein Struct. Mol. Enzymol., 2001, 1547(1), 51-56. doi: 10.1016/S0167-4838(01)00168-6 PMID: 11343790
  14. Jebali, J.; Bazaa, A.; Sarray, S.; Benhaj, K.; Karboul, A.; El Ayeb, M.; Marrakchi, N.; Gargouri, A. C-type lectin protein isoforms of Macrovipera lebetina: cDNA cloning and genetic diversity. Toxicon, 2009, 53(2), 228-237. doi: 10.1016/j.toxicon.2008.11.006 PMID: 19059426
  15. Sarray, S.; Berthet, V.; Calvete, J.J.; Secchi, J.; Marvaldi, J.; Ayeb, M.E.; Marrakchi, N.; Luis, J. Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells. Lab. Invest., 2004, 84(5), 573-581. doi: 10.1038/labinvest.3700088 PMID: 15048137
  16. Jebali, J.; Fakhfekh, E.; Morgen, M.; Srairi-Abid, N.; Majdoub, H.; Gargouri, A.; El Ayeb, M.; Luis, J.; Marrakchi, N.; Sarray, S. Lebecin, a new C-type lectin like protein from Macrovipera lebetina venom with anti-tumor activity against the breast cancer cell line MDA-MB231. Toxicon, 2014, 86, 16-27. doi: 10.1016/j.toxicon.2014.04.010 PMID: 24814013
  17. Sarray, S.; Delamarre, E.; Marvaldi, J.; Ayeb, M.E.; Marrakchi, N.; Luis, J. Lebectin and lebecetin, two C-type lectins from snake venom, inhibit α5β1 and αv-containing integrins. Matrix Biol., 2007, 26(4), 306-313. doi: 10.1016/j.matbio.2007.01.001 PMID: 17300927
  18. Sarray, S.; Srairi, N.; Hatmi, M.; Luis, J.; Louzir, H.; Regaya, I.; Slema, H.; Marvaldi, J.; El Ayeb, M.; Marrakchi, N. Lebecetin, a potent antiplatelet C-type lectin from Macrovipera lebetina venom. Biochim. Biophys. Acta. Proteins Proteomics, 2003, 1651(1-2), 30-40. doi: 10.1016/S1570-9639(03)00232-2 PMID: 14499586
  19. Sarray, S.; Srairi, N.; Luis, J.; Marvaldi, J.; El Ayeb, M.; Marrakchi, N. Lebecetin, a C-lectin protein from the venom of Macrovipera lebetina that inhibits platelet aggregation and adhesion of cancerous cells. Haemostasis, 2001, 31(3-6), 173-176. PMID: 11910182
  20. Montassar, F.; Darche, M.; Blaizot, A.; Augustin, S.; Conart, J.B.; Millet, A.; Elayeb, M.; Sahel, J.A.; Goazigo, A.R-L.; Sennlaub, F.; Marrakchi, N.; Messadi, E.; Guillonneau, X. Lebecetin, a C-type lectin, inhibits choroidal and retinal neovascularization. FASEB J., 2017, 31(3), 1107-1119. doi: 10.1096/fj.201600351R PMID: 27974593
  21. Jebali, J.; Zakraoui, O.; Aissaoui, D.; Abdelkafi-Koubaa, Z.; Srairi-Abid, N.; Marrakchi, N.; Essafi-Benkhadir, K. Lebecetin, a snake venom C-type lectin protein, modulates LPS-induced inflammatory cytokine production in human THP-1-derived macrophages. Toxicon, 2020, 187, 144-150. doi: 10.1016/j.toxicon.2020.09.001 PMID: 32918926
  22. Dina, O.A.; Parada, C.A.; Yeh, J.; Chen, X.; McCarter, G.C.; Levine, J.D. Integrin signaling in inflammatory and neuropathic pain in the rat. Eur. J. Neurosci., 2004, 19(3), 634-642. doi: 10.1111/j.1460-9568.2004.03169.x PMID: 14984413
  23. Hunskaar, S.; Hole, K. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain. Pain, 1987, 30(1), 103-114. doi: 10.1016/0304-3959(87)90088-1 PMID: 3614974
  24. Tjølsen, A.; Berge, O.G.; Hunskaar, S.; Rosland, J.H.; Hole, K. The formalin test: An evaluation of the method. Pain, 1992, 51(1), 5-17. doi: 10.1016/0304-3959(92)90003-T PMID: 1454405
  25. Tjolsen, A.; Hole, K. Animal models of analgesia. In: The Pharmacology of Pain; Dickenson, A.; Besson, J., Eds.; Springer Verlag: Berlin, 1997; 30, pp. 1-20. doi: 10.1007/978-3-642-60777-6_1
  26. Coderre, T.J.; Melzack, R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J. Neurosci., 1992, 12(9), 3671-3675. doi: 10.1523/JNEUROSCI.12-09-03671.1992 PMID: 1326611
  27. Gu, N.; Yi, M.H.; Murugan, M.; Xie, M.; Parusel, S.; Peng, J.; Eyo, U.B.; Hunt, C.L.; Dong, H.; Wu, L.J. Spinal microglia contribute to sustained inflammatory pain via amplifying neuronal activity. Mol. Brain, 2022, 15(1), 86. doi: 10.1186/s13041-022-00970-3 PMID: 36289499
  28. Schaible, H.G.; Richter, F. Pathophysiology of pain. Langenbecks Arch. Surg., 2004, 389(4), 237-243. doi: 10.1007/s00423-004-0468-9 PMID: 15034717
  29. Demirovic, D.; Rattan, S.I.S. Establishing cellular stress response profiles as biomarkers of homeodynamics, health and hormesis. Exp. Gerontol., 2013, 48(1), 94-98. doi: 10.1016/j.exger.2012.02.005 PMID: 22525591
  30. Schirrmacher, V. Less can be more: The hormesis theory of stress adaptation in the global biosphere and its implications. Biomedicines, 2021, 9(3), 293. doi: 10.3390/biomedicines9030293 PMID: 33805626
  31. Reynolds, A.R.; Hart, I.R.; Watson, A.R.; Welti, J.C.; Silva, R.G.; Robinson, S.D.; Da Violante, G.; Gourlaouen, M.; Salih, M.; Jones, M.C.; Jones, D.T.; Saunders, G.; Kostourou, V.; Perron-Sierra, F.; Norman, J.C.; Tucker, G.C.; Hodivala-Dilke, K.M. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med., 2009, 15(4), 392-400. doi: 10.1038/nm.1941 PMID: 19305413
  32. Monteiro, D.A.; Kalinin, A.L.; Selistre-de-Araujo, H.S.; Rantin, F.T. Hormetic-like dose-response induced by alternagin-C, a protein isolated from urutu snake (Rhinocerophis alternatus) venom, in fish (Hoplias malabaricus) cardiac contractility. Toxicon, 2022, 205, 67-70. doi: 10.1016/j.toxicon.2021.11.123 PMID: 34838810
  33. Miranti, C.K.; Brugge, J.S. Sensing the environment: A historical perspective on integrin signal transduction. Nat. Cell Biol., 2002, 4(4), E83-E90. doi: 10.1038/ncb0402-e83 PMID: 11944041
  34. Andrew, S.M.; Edwards, B.D.; Chalmers, R.J.G.; O’Driscoll, J.B. A quantitative immunohistochemical study of the expression of integrins by nerves in psoriatic and normal skin. Br. J. Dermatol., 1992, 127(4), 359-364. doi: 10.1111/j.1365-2133.1992.tb00454.x PMID: 1419755
  35. Tomaselli, K.J.; Doherty, P.; Emmett, C.J.; Damsky, C.H.; Walsh, F.S.; Reichardt, L.F. Expression of beta 1 integrins in sensory neurons of the dorsal root ganglion and their functions in neurite outgrowth on two laminin isoforms. J. Neurosci., 1993, 13(11), 4880-4888. doi: 10.1523/JNEUROSCI.13-11-04880.1993 PMID: 7693896
  36. Catalina, M.D.; Estess, P.; Siegelman, M.H. Selective requirements for leukocyte adhesion molecules in models of acute and chronic cutaneous inflammation: participation of E and P but not L-selectin. Blood, 1999, 93(2), 580-589. doi: 10.1182/blood.V93.2.580 PMID: 9885219
  37. Giancotti, F.G.; Ruoslahti, E. Integrin Signaling. Science, 1999, 285(5430), 1028-1033. doi: 10.1126/science.285.5430.1028 PMID: 10446041
  38. Berrier, A.L.; Mastrangelo, A.M.; Downward, J.; Ginsberg, M.; LaFlamme, S.E. Activated R-ras, Rac1, PI 3-kinase and PKCepsilon can each restore cell spreading inhibited by isolated integrin beta1 cytoplasmic domains. J. Cell Biol., 2000, 151(7), 1549-1560. doi: 10.1083/jcb.151.7.1549 PMID: 11134082
  39. Sachs, D.; Villarreal, C.F.; Cunha, F.Q.; Parada, C.A.; Ferreira, S.H. The role of PKA and PKCε pathways in prostaglandin E2-mediated hypernociception. Br. J. Pharmacol., 2009, 156(5), 826-834. doi: 10.1111/j.1476-5381.2008.00093.x PMID: 19220288
  40. Suzuki, K.; Grinnell, A.D.; Kidokoro, Y. Hypertonicity-induced transmitter release at Drosophila neuromuscular junctions is partly mediated by integrins and cAMP/protein kinase A. J. Physiol., 2002, 538(1), 103-119. doi: 10.1113/jphysiol.2001.012901 PMID: 11773320
  41. Dormond, O.; Bezzi, M.; Mariotti, A.; Rüegg, C. Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling. J. Biol. Chem., 2002, 277(48), 45838-45846. doi: 10.1074/jbc.M209213200 PMID: 12237321
  42. Geiger, B.; Bershadsky, A.; Pankov, R.; Yamada, K.M. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat. Rev. Mol. Cell Biol., 2001, 2(11), 793-805. doi: 10.1038/35099066 PMID: 11715046
  43. Marchand, F.; Perretti, M.; McMahon, S.B. Role of the Immune system in chronic pain. Nat. Rev. Neurosci., 2005, 6(7), 521-532. doi: 10.1038/nrn1700 PMID: 15995723
  44. Baral, P.; Udit, S.; Chiu, I.M. Pain and immunity: Implications for host defence. Nat. Rev. Immunol., 2019, 19(7), 433-447. doi: 10.1038/s41577-019-0147-2 PMID: 30874629
  45. Bauer, M.; Brakebusch, C.; Coisne, C.; Sixt, M.; Wekerle, H.; Engelhardt, B.; Fässler, R. β 1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity. Proc. Natl. Acad. Sci. USA, 2009, 106(6), 1920-1925. doi: 10.1073/pnas.0808909106 PMID: 19179279
  46. He, Y.; Gao, Y.; Zhang, Q.; Zhou, G.; Cao, F.; Yao, S. IL-4 switches microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH. Neuroscience, 2020, 437, 161-171. doi: 10.1016/j.neuroscience.2020.03.008 PMID: 32224230
  47. Cam, A.; de Mejia, E.G. RGD-peptide lunasin inhibits Akt-mediated NF-κB activation in human macrophages through interaction with the αVβ3 integrin. Mol. Nutr. Food Res., 2012, 56(10), 1569-1581. doi: 10.1002/mnfr.201200301 PMID: 22945510
  48. Peng, S.; Jia, J.; Sun, J.; Xie, Q.; Zhang, X.; Deng, Y.; Yi, L. LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells. Int. Immunopharmacol., 2019, 77, 105963. doi: 10.1016/j.intimp.2019.105963 PMID: 31732449
  49. Geijtenbeek, T.B.H.; Gringhuis, S.I. Signalling through C-type lectin receptors: Shaping immune responses. Nat. Rev. Immunol., 2009, 9(7), 465-479. doi: 10.1038/nri2569 PMID: 19521399
  50. Gringhuis, S.I.; den Dunnen, J.; Litjens, M.; van der Vlist, M.; Wevers, B.; Bruijns, S.C.M.; Geijtenbeek, T.B.H. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat. Immunol., 2009, 10(2), 203-213. doi: 10.1038/ni.1692 PMID: 19122653
  51. Sancho, D.; Reis e Sousa, C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol., 2012, 30(1), 491-529. doi: 10.1146/annurev-immunol-031210-101352 PMID: 22224766
  52. Mata-Martínez, P.; Bergón-Gutiérrez, M.; del Fresno, C. Dectin-1 signaling update: New perspectives for trained immunity. Front. Immunol., 2022, 13, 812148. doi: 10.3389/fimmu.2022.812148 PMID: 35237264
  53. Geijtenbeek, T.B.H.; Gringhuis, S.I. C-type lectin receptors in the control of T helper cell differentiation. Nat. Rev. Immunol., 2016, 16(7), 433-448. doi: 10.1038/nri.2016.55 PMID: 27291962
  54. Bliss, T.V.P.; Collingridge, G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature, 1993, 361(6407), 31-39. doi: 10.1038/361031a0 PMID: 8421494
  55. Dickenson, A.H.; Sullivan, A.F. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: Differential response to an intrathecal opiate administered pre or post formalin. Pain, 1987, 30(3), 349-360. doi: 10.1016/0304-3959(87)90023-6 PMID: 3670880
  56. Haley, J.E.; Dickenson, A.H.; Schachter, M. Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat. Neurosci. Lett., 1989, 97(1-2), 198-202. doi: 10.1016/0304-3940(89)90163-8 PMID: 2537479
  57. Haley, J.; Ketchum, S.; Dickenson, A. Peripheral κ-opioid modulation of the formalin response: An electrophysiological study in the rat. Eur. J. Pharmacol., 1990, 191(3), 437-446. doi: 10.1016/0014-2999(90)94178-Z PMID: 1964910
  58. Sullivan, A.F.; Dickenson, A.H.; Roques, B.P. δ-Opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones. Br. J. Pharmacol., 1989, 98(3), 1039-1049. doi: 10.1111/j.1476-5381.1989.tb14636.x PMID: 2556199

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers